Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine

Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine

MORRIS PLAINS, N.J., Feb. 20, 2019 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (&ldq...
read more